The Hematology Podcast - Season 5

Author : Sanofi

Editorial Team

Welcome to The Hematology Podcast, your source for the latest insights into hematology and rare blood disorders.

Welcome to The Hematology Podcast, your source for the latest insights into hematology and rare blood disorders. This podcast covers cutting-edge research, clinical advancements, and real-world cases tailored for healthcare professionals. Each episode offers expert perspectives on evolving therapies and best practices, helping you stay informed and improve patient outcomes. Whether you're focused on research or clinical practice, The Hematology Podcast is designed to keep you at the forefront of the field, transforming your approach to hematology.

Imagine a world where hematologic diseases can be detected earlier and treated more effectively through the power of artificial intelligence. That future is already here. Join us as we explore how AI is revolutionizing hematology through automatic identification of cell populations, early disease detection and prognosis and advanced machine learning applications.

Our distinguished guest, Dr. Oscar Brück, MD, PhD, leads the Hematoscope Lab at the Helsinki University Hospital Comprehensive Cancer Center & Center of Diagnostics and the University of Helsinki. His groundbreaking work combines high-resolution imaging, big data, and machine learning to tackle cancer heterogeneity head-on.

Expert guest

Oscar Brück
MD, PhD
Group leader of the Hematoscope Lab
Helsinki University Hospital

Immune Thrombocytopenia (ITP) is an autoimmune disorder characterized by a low platelet count, which can lead to increased bleeding and bruising. In this episode, we will discuss the pathophysiology, clinical implications, and advancements in ITP.

Our guest today, Professor Waleed Ghanima, is a renowned hematologist at Østfold Hospital and the University of Oslo in Norway. Prof. Ghanima has extensive experience in the field of hematology and has contributed significantly to research on ITP. Today, he will share his insights on ITP, its clinical management, and future directions in research and management.

Expert guest

Waleed Ghanima
Professor
Hematologist
Østfold hospital and the University of Oslo in Norway

A new genomic definition of high-risk multiple myeloma (HR-MM) has been recently proposed by IMS/IMWG. The associated peer-reviewed publication is planned to be released in Spring 2025.

Expert guest in this episode is Professor Monique Minnema, haematologist at the University Hospital in Utrecht in The Netherlands. She is an international expert with focus on diagnosis and treatment of malignant haematological diseases including Multiple Myeloma and Waldenström disease. She just recently accepted the vice-chair position of the HOVON Multiple Myeloma Working Group in the Netherlands.

Expert guest

Monique Minnema
Professor
Hematologist
University Hospital in Utrecht in The Netherlands

Get to know the host

In each episode, Dr. Mats Merup leads the interviews with the respective experts, providing a deep dive into the clinical, theoretical and practical aspects of the hematological field.

Associate professor Mats Merup, MD PhD (host)
Hematologist
Stockholm, Sweden

Mats Merup is an experienced clinical hematologist with an MD and PhD, specializing in malignant lymphomas and myeloproliferative disorders. He currently works in the clinical setting and has contributed to 50 published research publications as a clinical researcher.